PRNewsWire
Lindus Health Appoints Dr. Paul Billings to Scientific Advisory BoardPublished: 2026-01-08
Lindus
Lindus develops a platform for clinical trialling of new medicines, with the aim of increasing human trial participation and reducing the cost of bringing medicines to market.
Companies House ID
13298185
Incorporation Date
2021-03-29
Registered Name
Lindus Health Limited
Status
Active
Employee Count
100-249
Valuation
£231.15 million
Registered Address
65 Southwark Street
London
SE1 0HR
London (Greater)
London
SE1 0HR
London (Greater)
London
SE1 0HR
Financials
Summary
| 06 / 2024 | 06 / 2023 | 06 / 2022 | 06 / 2021 | |
|---|---|---|---|---|
| Turnover | £0.00 | £0.00 | £0.00 | £0.00 |
| Operating Profit | £0.00 | £0.00 | £0.00 | £0.00 |
| EBITDA | £0.00 | £0.00 | £0.00 | £0.00 |
| Total Assets | £0.00 | £0.00 | £0.00 | £0.00 |
| Total Liabilities | £0.00 | £0.00 | £0.00 | £0.00 |
| Net Assets | £0.00 | £0.00 | £0.00 | £0.00 |
| Cash | £0.00 | £0.00 | £0.00 | £0.00 |
| Employee count | £0.00 | £0.00 | £0.00 | £0.00 |
Turnover over time
No historic data available to display the chart.
Fundraising
| Fundraising rounds | 5 |
|---|---|
| Amount Raised | £9.99m |
| Transaction | Investor/s | Amount | Stage | Date |
|---|---|---|---|---|
| 15th Jan 2024 | Undisclosed investors | £1.5M | Venture | 15/01/2024 |
| 15th Jan 2024 | Undisclosed investors | £1.5M | Venture | 15/01/2024 |
| 15th Jan 2024 | Undisclosed investors | £1.5M | Venture | 15/01/2024 |
| 15th Jan 2024 | Undisclosed investors | £1.5M | Venture | 15/01/2024 |
| 15th Jan 2024 | Undisclosed investors | £1.5M | Venture | 15/01/2024 |
| 15th Jan 2024 | Undisclosed investors | £1.5M | Venture | 15/01/2024 |
| 15th Jan 2024 | Undisclosed investors | £1.5M | Venture | 15/01/2024 |
| 15th Jan 2024 | Undisclosed investors | £1.5M | Venture | 15/01/2024 |
| 15th Jan 2024 | Undisclosed investors | £1.5M | Venture | 15/01/2024 |
| 15th Jan 2024 | Undisclosed investors | £1.5M | Venture | 15/01/2024 |
| 15th Jan 2024 | Undisclosed investors | £1.5M | Venture | 15/01/2024 |
Unlock the full company profile
Access our live, verified company data on the Beauhurst platform. To get access — and find out exactly what you're missing — get in touch.
Signals and Classifiers
Signals
Classifiers
SIC Codes (2007)
Industries
Key People
Anthony Brogno
Clinical Operations Director
contact@company.comDamien Tiller
Vice President of Business Quality & Risk
contact@company.comEmma Ogburn
Vice President of Clinical Operations
contact@company.comGaby Field
Vice President of People & Operations
contact@company.comGemma Harrison
Chief Product & Technology Officer
contact@company.comGeorge Morriss
Talent Acquisition Director
contact@company.comHannah Gledhill
Chief of Staff, Programme Operations Director
contact@company.comHeather Davis
Vice President, Clinical Operations, Unites States
contact@company.comLina Wenner
Non-Executive Director
contact@company.comLouise Bautista
Head of Solutions
contact@company.comMeri Beckwith
Co-Founder & Co-Chief Executive Officer
contact@company.comMichael Young
Co-Founder
contact@company.comEmployee count over time
News
Fierce Biotech
Lindus Health and Quotient Sciences Partner for Streamlined Clinical TrialsPublished: 2025-12-17
Pharma Times
Lindus Health Teams Up with Quotient Sciences for Faster Drug DevelopmentPublished: 2025-12-16
PRNewsWire
Lindus Health and Quotient Sciences Collaborate on Clinical TrialsPublished: 2025-12-11
PRNewsWire
Lindus Health Names Heather Davis to Lead U.S. Clinical OperationsPublished: 2025-10-23
PRNewsWire
Lindus Health and Yendou Partner to Enhance Clinical Trial FeasibilityPublished: 2025-10-16
Contact
| Telephone | 020 0000 0000 |
| contact@company.com | |
| Website | https://www.lindushealth.com/ |
| Social Media |
Similar Companies
Unlock the full company profile
Access our live, verified company data on the Beauhurst platform. To get access — and find out exactly what you're missing — get in touch.